Hadassah Hospital’s Healing Tower
Construction of the new 14-storey hospital building is complete. It will replace the current 50 year-old round building, which will become Hadassah’s research and admin centre.
Israelis discover short-sightedness gene
Ben Gurion University researchers have identified a mutation of the gene LEPREL1 by studying a Bedouin tribe where the defect is the cause of hereditary myopia.
Morpheus gets US wake-up call
Israel biotech WideMed has obtained US Food and Drug Administration (FDA) approval for its sleep apnea monitoring system, Morpheus Ox, for home use.
Israeli breakthrough to save species
Israeli scientist Dr. Inbar Friedrich Ben-Nun is leading a US team that has produced the first stem cells from endangered species and could save animals from extinction. This report was also broadcast on BBC World Service – without mentioning that the lead scientist was Israeli!
MRI scan performs virtual autopsies
A new MRI device that can accurately determine cause of death was inaugurated at Assaf Harofeh Hospital. The systems allow doctors to view the inside of the body and observe the condition of organs and other internal components without the need to cut open the body.
How to stay healthy
Happier and more optimistic men have 20 percent more chance of staying alive than pessimistic ones. So Israeli biotech Synapsot has set-up what they call a “toolbox for optimistic health”.
Medical support for Palestinian Arabs
Last year Israel treated 83,000 Palestinian Arabs like 29 year-old, mother of five, Baraa Inhabi. This is a “must-see” film clip, in order to appreciate what really goes on.
Treatment for cancer and alcoholism
The Deep Transcranial Magnetic Stimulation (TMS) devices being tested by Israel’s Brainsway work for both malignant brain tumours and alcoholic addiction.
Dead Sea dip helps diabetics
Just being in Israel can be beneficial to one’s health. Ben Gurion scientists have shown that 20 minutes in Dead Sea water reduces blood glucose levels by an average of 13.5 percent.
US approves Israeli treatment for Buerger’s disease
Israel biotech Pluristem has received orphan drug status from the US Food and Drugs Administration for its stem cell treatment of blood vessels disease.